Gastrointestinal stromal tumours: origin and molecular oncology
- PMID: 22089421
- DOI: 10.1038/nrc3143
Gastrointestinal stromal tumours: origin and molecular oncology
Abstract
Gastrointestinal stromal tumours (GISTs) are a paradigm for the development of personalized treatment for cancer patients. The nearly simultaneous discovery of a biomarker that is reflective of their origin and the presence of gain-of-function kinase mutations in these tumours set the stage for more accurate diagnosis and the development of kinase inhibitor therapy. Subsequent studies of genotype and phenotype have led to a molecular classification of GIST and to treatment optimization on the basis of molecular subtype. The study of drug-resistant tumours has advanced our understanding of kinase biology, enabling the development of novel kinase inhibitors. Further improvements in GIST treatment may require targeting GIST stem cell populations and/or additional genomic events.
Similar articles
-
The role of KIT in the management of patients with gastrointestinal stromal tumors.Hum Pathol. 2007 May;38(5):679-87. doi: 10.1016/j.humpath.2007.03.001. Hum Pathol. 2007. PMID: 17437861 Review.
-
Molecular research directions in the management of gastrointestinal stromal tumors.Curr Treat Options Oncol. 2005 Nov;6(6):473-86. doi: 10.1007/s11864-005-0026-x. Curr Treat Options Oncol. 2005. PMID: 16242052 Review.
-
Systemic therapy for advanced gastrointestinal stromal tumors: beyond imatinib.J Surg Oncol. 2011 Dec;104(8):901-6. doi: 10.1002/jso.21872. J Surg Oncol. 2011. PMID: 22069175 Review.
-
Practical role of mutation analysis for imatinib treatment in patients with advanced gastrointestinal stromal tumors: a meta-analysis.PLoS One. 2013 Nov 4;8(11):e79275. doi: 10.1371/journal.pone.0079275. eCollection 2013. PLoS One. 2013. PMID: 24223922 Free PMC article.
-
Gastrointestinal stromal tumor and its targeted therapeutics.Chin J Cancer. 2011 May;30(5):303-14. doi: 10.5732/cjc.011.10062. Chin J Cancer. 2011. PMID: 21527063 Free PMC article. Review.
Cited by
-
Molecular characterization of an Italian series of sporadic GISTs.Gastric Cancer. 2013 Oct;16(4):596-601. doi: 10.1007/s10120-012-0213-y. Epub 2013 Jan 5. Gastric Cancer. 2013. PMID: 23291969
-
Skin Metastasis of Gastrointestinal Stromal Tumors: A Case Series and Literature Review.Cancer Manag Res. 2020 Aug 24;12:7681-7690. doi: 10.2147/CMAR.S261823. eCollection 2020. Cancer Manag Res. 2020. PMID: 32904396 Free PMC article.
-
Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors.Cancer Med. 2020 Sep;9(18):6485-6496. doi: 10.1002/cam4.3212. Epub 2020 Jul 22. Cancer Med. 2020. PMID: 32697050 Free PMC article.
-
Inhibition of KIT Tyrosine Kinase Activity: Two Decades After the First Approval.J Clin Oncol. 2021 May 20;39(15):1674-1686. doi: 10.1200/JCO.20.03245. Epub 2021 Apr 2. J Clin Oncol. 2021. PMID: 33797935 Free PMC article. No abstract available.
-
Association between calcification and risk stratification in gastric gastrointestinal stromal tumors.Abdom Radiol (NY). 2024 Aug 24. doi: 10.1007/s00261-024-04544-w. Online ahead of print. Abdom Radiol (NY). 2024. PMID: 39180668
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources